Centre approves increase in production of Remdesivir and reducing its prices

ED has been directed to act against black marketing of Remdesivir

The government has decided to increase the production and supply of Remdesivir and also to reduce its prices in the country. It has approved seven additional sites having a production capacity of 10 Lakh vials per month to six manufacturers.

The current total installed capacity of the seven manufacturers of Remdesivir in the country is 38 lakh 80 thousand vials per month. Minister of State for Chemicals and Fertilizers Mansukh Mandaviya today reviewed the issue of availability of Remdesivir in the country.

The Ministry said, another 30 lakh vials per month production is lined up. This will ramp up the production capacity for manufacturing to around 78 lakh vials per month. Earlier the government had prohibited exports of injection Remdesivir to increase the supply in the Domestic Market.


The Ministry said, manufacturers of Remdesivir have volunteered to reduce the price to less than 3,500 by the end of this week, to support the efforts to Fight against COVID. The manufactures have been directed to give priority to fulfil hospital and institutional level supplies.

Enforcement Authorities of States and Central Government have also been directed by Drugs Controller General of India, DCGI to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir. The Ministry said National Pharmaceutical Pricing Authority is continuously monitoring the availability of Remdesivir.

Tags : #CentralGovernment #Remdesivir #DCGI #ED #EnforcementDiectorate #RemdesivirBlackMarketing

About the Author


Team Medicircle

Related Stories

01 Jun

The DCGI has given ENTOD Pharma approval for phase 3 trials of its myopia eye drop

Myopia is the most common cause of visual impairment in children, and according to an AIIMS research, 17% of children, or 1 in every 6 children in India between the ages of 5 and 15 years, suffer from myopia."

View
14 Feb

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

Latest corporate news update; Pharma

View
07 Feb

Dr Reddy will acquire a German medical cannabis firm Nimbus Health

German-based Nimbus Health has been a major player in the field of cannabis-based medicines segment. The acquisition will allow Dr Reddy to build on Nimbus Health’s current offerings and introduce new cannabis-based medical products.

View
12 Oct

Covaxin gets EUA for children aged 2-18 years

The Subject Expert Committee (SEC) has approved emergency use of Bharat Biotech's Covaxin for children in the 2-18 years age group

View
21 Sep

Sputnik Light vs Sputnik V – Know the difference

All about Russia’s Sputnik vaccine

View
16 Sep

Growth of India’s Pharmaceutical Companies

Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had captured 85% of the market.

View
15 Sep

DCGI permits ‘Sputnik Light’ to conduct Phase III trials in India

The Drug Controller General of India has approved the single-dose COVID vaccine Sputnik Light to conduct phase 3 trials on the Indian population

View
28 Jun

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine. We are extremely pleased to have partnered with DRDO in our collective fight against the COVID-19 pandemic.

View
28 Jun

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine. We are extremely pleased to have partnered with DRDO in our collective fight against the COVID-19 pandemic.

View
22 Jun

Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market

Dr. Reddy’s Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120’s count.

View

-Advertisements-




Trending Now

Teenagers Are Losing Friends While Chasing Perfection: Here’s WhyMarch 13, 2025
Your Desk Job is Destroying Your Mind: Here’s How to Fight BackMarch 13, 2025
Wow! Momo Disrupts FMCG Cup Noodles Market with 'Desi-Asian Flavours' – A First in IndiaMarch 13, 2025
How India’s Kidney Health Crisis is Growing UnnoticedMarch 13, 2025
Stuck Between the Snooze Button and the Hustle: Entrepreneurs Struggle to Get Quality SleepMarch 13, 2025
Can Coffee Keep You Steady on Your Feet? New Study Reveals the TruthMarch 13, 2025
NephroPlus Sets Guinness World Record & India Book of Records Title for Largest Kidney Health Screening DriveMarch 12, 2025
India Choosing to Eat Healthy; Order Volumes Up by 60% for Nutritional ProductsMarch 12, 2025
Amrita students win first prize at DecodeX 2025 hackathonMarch 12, 2025
Why Millions Are Losing Their Sight to Glaucoma And How You Can Prevent ItMarch 12, 2025
Çelebi India Ranks 3rd Worldwide in Ground Handling Performance for Turkish CargoMarch 12, 2025
Advancing Road Safety Through Clear Vision: VARS 4.0 Sets Bold AgendaMarch 12, 2025
The Deadly Cost of the “Perfect Body”: When Diet Trends Turn FatalMarch 12, 2025
Lighthouse Canton’s LC GenInnov Global Innovation Fund Secures Investment from Kotak Mahindra Asset ManagementMarch 11, 2025
TTK Prestige Revolutionizes Cooking with Innovative AirFlip Two-in-One Air Fryer and GrillMarch 11, 2025
Rewriting Immunology: The Discovery That Could Replace Traditional AntibioticsMarch 11, 2025
Is Your Cooking Oil Poisoning You? The Truth About Seed OilsMarch 11, 2025
Think Before You Bite: How Fatty Foods Can Trigger Brain Damage in Just 3 DaysMarch 11, 2025
Ditch the Pills: The Secret to Beating Insomnia is in Your WorkoutMarch 11, 2025
The University of Tasmania invites applications for Master of Public HealthMarch 11, 2025